La vendita allo scoperto per Westwater Resources dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Westwater Resources. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Westwater Resources (AMEX:WWR) Azioni, Report sulle vendite allo scoperto

Westwater Resources

Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.

Westwater Resources Inc

WORLD WIRELESS COMMUN INC by World Wireless Communications Inc.

World Wireless Communications Inc

Scotiabank analyst Patrick Colville maintains CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) with a Sector Outperform and raises the price target from $340 to $400.

News

Price Target

Analyst Ratings

CYBR

Scotiabank Maintains Sector Outperform on CyberArk Software, Raises Price Target to $400

Whales with a lot of money to spend have taken a noticeably bullish stance on Hims &amp; Hers Health.
Looking at options history for Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) we detected 20 trades.
If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish expectations and 35% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $315,490 and 15, calls, for a total amount of $738,711.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $40.0 for Hims &amp; Hers Health over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Hims &amp; Hers Health's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims &amp; Hers Health's whale activity within a strike price range from $15.0 to $40.0 in the last 30 days. 
<h3>Hims &amp; Hers Health 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737485150_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/14/25</td>
<td>$2.5</td>
<td>$2.34</td>
<td>$2.48</td>
<td>$30.00</td>
<td>$123.5K</td>
<td>374</td>
<td>1.8K</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/14/25</td>
<td>$2.56</td>
<td>$2.43</td>
<td>$2.48</td>
<td>$30.00</td>
<td>$123.5K</td>
<td>374</td>
<td>1.1K</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.96</td>
<td>$1.82</td>
<td>$1.95</td>
<td>$15.00</td>
<td>$97.1K</td>
<td>4.1K</td>
<td>3.0K</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.88</td>
<td>$1.86</td>
<td>$1.88</td>
<td>$15.00</td>
<td>$94.0K</td>
<td>4.1K</td>
<td>1.4K</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/14/25</td>
<td>$2.45</td>
<td>$2.44</td>
<td>$2.45</td>
<td>$30.00</td>
<td>$56.6K</td>
<td>374</td>
<td>593</td>
</tr>
</tbody>
</table>

<h3>About Hims &amp; Hers Health</h3>
Hims &amp; Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
In light of the recent options history for Hims &amp; Hers Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Hims &amp; Hers Health</h3>
<ul>
<li>With a volume of 7,671,616, the price of HIMS is up 6.7% at $29.71. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 34 days.</li>
</ul>
<h3>What Analysts Are Saying About Hims &amp; Hers Health</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $28.75.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler has decided to maintain their Neutral rating on Hims &amp; Hers Health, which currently sits at a price target of $24. 
&#x2A; An analyst from Needham persists with their Buy rating on Hims &amp; Hers Health, maintaining a target price of $31. 
&#x2A; An analyst from Citigroup has revised its rating downward to Sell, adjusting the price target to $25. 
&#x2A; In a cautious move, an analyst from BTIG downgraded its rating to Buy, setting a price target of $35. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Hims &amp; Hers Health options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on SoundHound AI.
Looking at options history for SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) we detected 20 trades.
If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 45% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $782,901 and 12, calls, for a total amount of $609,727.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $5.5 to $26.0 for SoundHound AI over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for SoundHound AI's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of SoundHound AI's whale activity within a strike price range from $5.5 to $26.0 in the last 30 days. 
<h3>SoundHound AI Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737485145_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SOUN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$4.9</td>
<td>$4.85</td>
<td>$4.9</td>
<td>$18.00</td>
<td>$356.7K</td>
<td>25</td>
<td>1.0K</td>
</tr>
<tr>
<td>SOUN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$5.1</td>
<td>$5.05</td>
<td>$5.1</td>
<td>$12.00</td>
<td>$190.7K</td>
<td>2.5K</td>
<td>52</td>
</tr>
<tr>
<td>SOUN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$4.9</td>
<td>$4.85</td>
<td>$4.9</td>
<td>$18.00</td>
<td>$133.2K</td>
<td>25</td>
<td>303</td>
</tr>
<tr>
<td>SOUN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/24/25</td>
<td>$8.6</td>
<td>$8.4</td>
<td>$8.5</td>
<td>$24.00</td>
<td>$127.5K</td>
<td>313</td>
<td>163</td>
</tr>
<tr>
<td>SOUN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.35</td>
<td>$3.25</td>
<td>$3.35</td>
<td>$15.00</td>
<td>$60.3K</td>
<td>592</td>
<td>499</td>
</tr>
</tbody>
</table>

<h3>About SoundHound AI</h3>
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers.
Having examined the options trading patterns of SoundHound AI, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of SoundHound AI</h3>
<ul>
<li>With a trading volume of 65,236,287, the price of SOUN is up by 12.75%, reaching $15.38.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 37 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for SoundHound AI</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $20.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from HC Wainwright &amp; Co. lowers its rating to Buy with a new price target of $26. 
&#x2A; Consistent in their evaluation, an analyst from HC Wainwright &amp; Co. keeps a Buy rating on SoundHound AI with a target price of $26. 
&#x2A; Maintaining their stance, an analyst from Northland Capital Markets continues to hold a Market Perform rating for SoundHound AI, targeting a price of $8. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for SoundHound AI, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

SOUN

Unpacking the Latest Options Trading Trends in SoundHound AI

Whales with a lot of money to spend have taken a noticeably bearish stance on Snowflake.
Looking at options history for Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) we detected 70 trades.
If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 51% with bearish.
From the overall spotted trades, 12 are puts, for a total amount of $1,174,639 and 58, calls, for a total amount of $5,527,308.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $300.0 for Snowflake, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Snowflake's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Snowflake's whale activity within a strike price range from $60.0 to $300.0 in the last 30 days. 
<h3>Snowflake Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737485140_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$126.6</td>
<td>$121.7</td>
<td>$121.7</td>
<td>$60.00</td>
<td>$523.9K</td>
<td>45</td>
<td align="right">77</td>
</tr>
<tr>
<td>SNOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$70.45</td>
<td>$66.0</td>
<td>$70.45</td>
<td>$230.00</td>
<td>$338.1K</td>
<td>0</td>
<td align="right">51</td>
</tr>
<tr>
<td>SNOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$38.55</td>
<td>$35.8</td>
<td>$38.55</td>
<td>$180.00</td>
<td>$211.8K</td>
<td>9</td>
<td align="right">97</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.75</td>
<td>$3.65</td>
<td>$3.6</td>
<td>$210.00</td>
<td>$198.0K</td>
<td>4.7K</td>
<td align="right">587</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$88.3</td>
<td>$84.9</td>
<td>$84.9</td>
<td>$110.00</td>
<td>$144.3K</td>
<td>81</td>
<td align="right">17</td>
</tr>
</tbody>
</table>

<h3>About Snowflake</h3>
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that went public in 2020. To date, the company has over 3,000 customers, including nearly 30% of the Fortune 500. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to buy and ingest data, while its data solutions can be hosted on various public clouds.
<h3>Snowflake's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,019,870, with SNOW's price up by 2.36%, positioned at $174.81.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 36 days.</li>
</ul>
<h3>Expert Opinions on Snowflake</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $200.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $201. 
&#x2A; Showing optimism, an analyst from Wells Fargo upgrades its rating to Overweight with a revised price target of $200. 
&#x2A; Maintaining their stance, an analyst from Loop Capital continues to hold a Buy rating for Snowflake, targeting a price of $205. 
&#x2A; Showing optimism, an analyst from Barclays upgrades its rating to Overweight with a revised price target of $190. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Snowflake with a target price of $208. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Snowflake options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

SNOW

Looking At Snowflake's Recent Unusual Options Activity

Scotiabank analyst Patrick Colville maintains Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) with a Sector Perform and raises the price target from $87 to $110.

Scotiabank Maintains Sector Perform on Cloudflare, Raises Price Target to $110

Scotiabank analyst Brandon Bingham maintains Kinetik Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNTK#NYSE">KNTK</a>) with a Sector Outperform and lowers the price target from $64 to $62.

KNTK

Scotiabank Maintains Sector Outperform on Kinetik Holdings, Lowers Price Target to $62

On Monday, the European Commission approved GSK plc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) Jemperli&nbsp;(dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult patients with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy.
The <a target="_blank" href="https://www.gsk.com/en-gb/media/press-releases/european-commission-expands-jemperli-dostarlimab-plus-chemotherapy-approval-to-all-adult-patients-with-primary-advanced-or-recurrent-endometrial-cancer/" rel="noreferrer noopener">approval</a> broadens the previous indication for&nbsp;Jemperli&nbsp;plus chemotherapy in the European Union (EU) to include patients with mismatch repair proficient (MMRp)/microsatellite stable (MSS) tumors, which represent approximately 75% of patients diagnosed with endometrial cancer and who have limited treatment options.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/43010436/gsk-highlights-new-approvals-vaccine-momentum-at-jp-morgan-healthcare-conference" rel="noreferrer noopener">GSK Highlights New Approvals, Vaccine Momentum At JPMorgan Healthcare Conference</a>
The European Commission&#8217;s approval to expand the use of&nbsp;Jemperli&nbsp;plus chemotherapy is based on results from Part 1 of the RUBY phase 3 trial.
The company says RUBY Part 1 is the only clinical trial in this setting to show a clinically meaningful and statistically significant overall survival benefit in the full population of patients with primary advanced or recurrent endometrial cancer, showing a 31% reduction in risk of death compared to chemotherapy alone.
At the 2.5-year landmark, the chance of being alive was 61% for the&nbsp;Jemperli&nbsp;plus chemotherapy group (245 patients) compared to 49% in the chemotherapy group (249 patients).
In addition, a 16.4-month improvement in median OS was observed with Jemperli plus chemotherapy versus chemotherapy alone. The median duration of follow-up was more than three years.
The safety and tolerability analysis from RUBY Part 1 showed a safety profile for&nbsp;Jemperli&nbsp;plus carboplatin-paclitaxel that was generally consistent with the known safety profiles of the individual agents.
The label for&nbsp;Jemperli&nbsp;plus chemotherapy in the U.S. was expanded to all adult patients with primary advanced or recurrent endometrial cancer in August 2024.
Recently, GSK agreed to acquire&nbsp;IDRx, Inc., a biopharmaceutical company focused on precision therapeutics for&nbsp;gastrointestinal stromal tumors, <a target="_blank" href="https://www.benzinga.com/25/01/42950025/gsk-to-buy-us-based-stomach-cancer-drug-developer-for-over-1-billion" rel="noreferrer noopener">for $1 billion</a>.
Price Action: GSK stock is up 0.76% at $33.69 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43102213/whats-going-on-with-the-stock-of-foresight-autonomous-today" target="_blank" rel="noreferrer noopener">Foresight Autonomous Inks Commercial Cooperation Pact With Autonomous Drone Manufacturer: Details</a></li>
</ul>
Photo by HJBC via Shutterstock.

Biotech

Equities

Large Cap

Health Care

General

Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer

WIIM

Trump Media & Technology shares are trading lower following Donald Trump's inauguration.

Scotiabank analyst Brandon Bingham maintains Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) with a Sector Outperform and raises the price target from $242 to $247.

Scotiabank Maintains Sector Outperform on Cheniere Energy, Raises Price Target to $247

Scotiabank analyst Patrick Colville maintains Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) with a Sector Outperform and raises the price target from $200 to $215.

CHKP

Scotiabank Maintains Sector Outperform on Check Point Software, Raises Price Target to $215

Scotiabank analyst Orest Wowkodaw maintains Capstone Copper (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CS#TSX">CS</a>) with a Sector Outperform and lowers the price target from C$12 to C$11.

TSX:CS

Scotiabank Maintains Sector Outperform on Capstone Copper, Lowers Price Target to C$11

PTON

Peloton Interactive Option Alert: Mar 21 $9 Calls at the Ask: 5000 @ $1.02 vs 998 OI; Earnings 2/3 Before Open [est] Ref=$8.435

On Monday, BrightSpring Health Services Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>) agreed to sell its Community Living business, ResCare Community Living, to Sevita for <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g43087445/brightspring-health-services-inc-enters-into-definitive-agreement-to-divest-community-living-busin" rel="noreferrer noopener">$835 million in cash</a>.
The deal, set to close in 2025, aligns with BrightSpring&#8217;s strategic focus on enhancing its core services, including home health, hospice, primary care, rehabilitation, and pharmacy solutions.
After the divestiture, the company expects to realize additional operational efficiencies across the BrightSpring platform, with a more synergistic overall portfolio of service offerings. The transaction is expected to be accretive to both Company and Provider Services Revenue growth and Adjusted EBITDA growth.
Post-sale, BrightSpring expects its Provider Services portfolio to exhibit stronger revenue growth and adjusted EBITDA, supported by an optimized payer mix and a focus on high-demand growth markets.
The company also anticipates accelerated deleveraging, aiming to reduce its long-term debt-to-EBITDA ratio to below 3.0x.
The Community Living business, which generated approximately $1.2 billion in revenue and $128 million in adjusted EBITDA in 2024, includes&nbsp;14,000 clients and 13,500 employees. BrightSpring anticipates after-tax proceeds of $715 million, which will be primarily allocated toward debt reduction, improving the company&#8217;s financial position.
The company reported preliminary 2024 sales of $11.2 billion-$11.3 billion, or a year over year increase of 26.9%- 28.0%, compared to <a href="https://www.benzinga.com/calendars/guidance">consensus of $11.17 billion.</a>
<ul>
<li>Pharmacy Segment Revenue is expected to be $8.7 billion-$8.75 billion.</li>
<li>Provider Segment Revenue of $2.5 billion-$2.55 billion; Community Living Revenue in 2024 is expected to be $1.2 billion.</li>
<li>Adjusted EBITDA is expected to be approximately $588 million, with Community Living Adjusted EBITDA of approximately $128 million.</li>
</ul>
For 2025, the company expects sales of $11.5 billion-$12 billion compared to a consensus of $12.39 billion.
<ul>
<li>Pharmacy Segment Revenue of $10.05 billion-$10.5 billion and Provider Segment Revenue of $1.45 billion-$1.5 billion.</li>
<li>Adjusted EBITDA of $540 million- $555 million.</li>
</ul>
Price Action: BTSG stock is up 13.6% at $21.08 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/43102451/valneva-chikungunya-vaccine-shows-high-sustained-immune-response-in-adolescents-one-year-after-single-shot" target="_blank" rel="noreferrer noopener">Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot</a></li>
</ul>
Photo via Shutterstock.

Guidance

Asset Sales

Movers

Trading Ideas

BTSG

BrightSpring Health Divests Community Living Business For $850 Million To Focus On Core Activities

Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) is set to report its fourth-quarter financial results after Tuesday's closing bell. Here's a look at what investors will be watching when the financial <a href="https://www.benzinga.com/general/market-summary/25/01/42871340/regional-banks-can-thrive-despite-big-bank-dominance-truist-securities-highlights-three-key-paths-for-thriving-regional-banks">services company reports. </a>
What To Know: Wall Street will be interested in the performance of Capital One&#8217;s credit card segment, particularly its domestic card business. Net charge-off rates and delinquency rates are often seen as a barometer for the health of the U.S. consumer. 
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/01/43106379/trump-reverses-bidens-ai-policies-on-day-1-what-it-means-for-tech-giants-nvidia-amd-alphabet">Trump Reverses Biden&#8217;s AI Policies On Day 1: What It Means For Tech Giants Nvidia, AMD, Alphabet&nbsp;</a>
Rising charge-offs and delinquency rates may also be a point of concern for investors, as they could potentially lead to higher losses for Capital One in the future. The company reported its net charge-off rate was 5.6% in the third quarter, slightly above analyst estimates of 5.5% and the 30-plus day performing delinquency rate for the overall portfolio was 3.71% in the third quarter, up from 3.42% in the previous quarter. 
According to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, analysts expect Capital One Financial to report earnings of $2.82 per share and quarterly revenue of $10.21 billion after Tuesday's closing bell.&nbsp;
What Else: Investors will also be looking for any comments or financial impacts related to <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42981370/cfpb-sues-capital-one-over-alleged-2-billion-in-lost-interest-for-consumers">the recent lawsuit</a> filed by the Consumer Financial Protection Bureau regarding interest rates on its savings accounts.&nbsp;
The CFPB's lawsuit alleges Capital One deliberately misled customers by hiding its more lucrative 360 Performance Savings account while falsely advertising its 360 Savings account as offering one of the best interest rates in the nation.&nbsp;
COF Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Capital One shares are up 1.25% at $193.34 at the time of publication Tuesday. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/initiation/25/01/43102452/roku-analyst-sees-25-upside-as-tv-ad-dollars-go-digital">Roku Analyst Sees 25% Upside As TV Ad Dollars Go Digital&nbsp;</a></li>
</ul>
Image: Shutterstock

Earnings

Previews

Legal

Capital One To Report Q4 Results: Here's What To Watch

Scotiabank analyst Tanya Jakusconek maintains Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) with a Sector Perform and lowers the price target from $52 to $50.

Scotiabank Maintains Sector Perform on Newmont, Lowers Price Target to $50

Binary Options

QBTS

D-Wave Quantum Option Alert: Jan 31 $7.5 Calls Sweep (6) near the Ask: 840 @ $0.351 vs 2126 OI; Ref=$6.125

Scotiabank analyst Tanya Jakusconek maintains Eldorado Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGO#NYSE">EGO</a>) with a Sector Perform and lowers the price target from $20 to $18.5.

Scotiabank Maintains Sector Perform on Eldorado Gold, Lowers Price Target to $18.5

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 450 points on Tuesday.
The Dow traded up 1.07% to 43,951.84 while the NASDAQ rose 0.71% to 19,770.38. The S&amp;P 500 also rose, gaining, 0.85% to 6,047.41.
Check This Out: <a href="https://www.benzinga.com/25/01/43091705/top-4-health-care-stocks-you-may-want-to-dump-in-q1">Top 4 Health Care Stocks You May Want To Dump In Q1</a>
Leading and Lagging Sectors Utilities shares surged by 1.6% on Tuesday.
In trading on Tuesday, energy shares fell by 0.6%.
Top Headline
D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) reported better-than-expected first-quarter results.
Sales fell 1% year-over-year to $7.61 billion, beating the consensus of $7.08 billion. EPS was $2.61, beating the consensus of $2.44.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Evolus Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOLS#NASDAQ">EOLS</a>) shares shot up 32% to $13.92 after the company announced it expects FDA approval for Evolysse gels within 90 days and is eyeing a second-quarter 2025 rollout in the US. Additionally, the company reported FY24 revenue results and provided FY25 guidance.</li>
<li>Shares of Helius Medical Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>)got a boost, surging 41% to $1.06 after the company announced it exceeded its initial enrollment target for its stroke pivotal study.</li>
<li>InMed Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INM#NASDAQ">INM</a>) shares were also up, gaining 36% to $6.75 after the company announced that INM-901 reduced Alzheimer &#8216;s-related inflammation in a preclinical study.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Canoo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) shares dropped 66% to $0.46 after the electric vehicle company filed for Chapter 7 bankruptcy.</li>
<li>Shares of FTAI Aviation Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) were down 30% to $78.35 after the company announced it may delay its FY24 10-K filing.</li>
<li>New Oriental Education &amp; Tech Grp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) was down, falling 24% to $46.26 after the company reported a second-quarter EPS miss.</li>
</ul>
Commodities In commodity news, oil traded down 2.3% to $76.09 while gold traded down 0.1% at $2,748.20.
Silver traded up 0.6% to $31.335 on Tuesday, while copper fell 1.4% to $4.3070.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 surged 0.16%, Germany's DAX 40 rose 0.05% and France's CAC 40 gained 0.33%. Spain's IBEX 35 Index fell 0.15%, while London's FTSE 100 gained 0.07%.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 falling 0.31%, China's Shanghai Composite Index gaining 0.18%, Hong Kong's Hang Seng Index climbing 0.31% and India's BSE Sensex falling 0.55%.
Economics
No major economic reports are scheduled for release today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43093684/this-analyst-with-86-accuracy-rate-sees-around-18-upside-in-bank-of-america-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts">This Analyst With 86% Accuracy Rate Sees Around 18% Upside In Bank of America &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Eurozone

Commodities

New Oriental Education & Technology Group

EOLS

FTAI

GOEV

HSDT

Crude Oil Down 2%; D.R. Horton Earnings Top Views

Citigroup Must Face New York Attorney General Lawsuit Over Fraud Scams, Judge Rules; Some Claims Are Dismissed

Scotiabank analyst Tanya Jakusconek maintains Agnico Eagle Mines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEM#NYSE">AEM</a>) with a Sector Outperform and raises the price target from $103 to $105.

Scotiabank Maintains Sector Outperform on Agnico Eagle Mines, Raises Price Target to $105

Graphite Miners News For The Month Of August 2024

Westwater Resources (WWR) just unveiled an update. Westwater Resources, Inc. has entered into financial agreements to bolster its capital through e...

Westwater Resources Secures Equity Financing Deals

Westwater Resources files secondary offering of common stock

Westwater Resources wins offtake deal for Kellyton Fines graphite production

Graphite Miners News For The Month Of September 2024

Graphite Miners News For The Month Of October 2024

Westwater Resources GAAP EPS of -$0.05

Westwater Resources ( ($WWR) ) has released its Q3 earnings. Here is a breakdown of the information Westwater Resources presented to its investors....

Westwater Resources Reports Q3 2024 Financial Results

Graphite Miners News For The Month Of November 2024

Graphite Miners News For The Month Of December 2024

AMVMF

APMFF

BSSMF

CBULF

CYLYF

DMNKF

ECGFF

ECORF

EVMIF

FCSMF

FGPHF

GBMIF

GEMSF

GPHOF

GRFX

GRFXF

IMYSF

IMYSY

LEMIF

LMRMF

MGPHF

MNSEF

NGPHF

NNXPF

NSRCF

NVNXF

RFLXF

SGLFF

SRHYY

STSBF

SVMLF

SYAAF

TLGRF

TORVF

ZTEK

Westwater Resources announces major graphite sales agreement with Fiat Chrysler

Press Releases

Westwater Resources Announces Second Quarter 2024 Updates

Westwater Resources to Present at the 2024 Gateway Conference on September 4, 2024

Westwater Resources to Present at the 2024 Gateway Conference on September 4th

Westwater Resources Enters into Exclusivity for $150 million Secured Debt Facility with a Global Financial Institution

Westwater Resources Announces Off-Take Agreement for Sale of 100% of Fines Graphite Production from its Kellyton Plant

Westwater Resources Supports Office of the United States Trade Representative Decision to Implement Section 301 Tariffs on Natural Graphite

Westwater Resources Applauds Treasury Department Guidance on 45X Advanced Manufacturing Production Credit

Westwater Resources Announces Third Quarter 2024 Updates

Westwater Resources Expects Kellyton Debt Financing to Close in January 2025

AMERICAN

Advent Technologies Holdings, Inc. - Class A Common Stock

Advent Technologies Hldgs

Asia Pacific Wire & Cable Corporation Limited - Common shares, Par value .01 per share

Comments

Westwater Resources

Vendite allo scoperto

Westwater Resources (AMEX:WWR) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO